PLEDGE MODIFICATION AGREEMENT OF JUBILANT PHARMA PTE. LIMITED, SINGAPOREPledge Modification Agreement • June 1st, 2011 • Cadista Holdings Inc. • New York
Pledge Modification Agreement made this 25 day of Sept, 2007, among JUBILANT PHARMA PTE. LTD. (hereinafter “Pledgor”), a Singapore corporation, with its registered address at 42 B Horne Road, Singapore, 209066, STATE BANK OF INDIA, NEW YORK BRANCH, a banking corporation duly licensed by the Superintendent of Banks of the State of New York and having its place of business at 460 Park Avenue, New York, N.Y. 10022, Facility Arranger, Administrative Agent, and Senior Lender (hereinafter, “Agent”), BANK OF BARODA, a banking corporation duly licensed by the Superintendent of Banks of the State of New York, and having its place of business at 1 Park Avenue, New York, NY 10016 (hereinafter, “BOB”), CADISTA PHARMACEUTICALS INC., a Delaware corporation with its principal place of business at 207 Kiley Drive, Salisbury MD, formerly known as Jubilant Pharmaceuticals Inc., (hereinafter “Borrower”), and CADISTA HOLDINGS INC. (“Cadista”) formerly known as Trigen Laboratories Inc, a Delaware corporati
PLEDGE MODIFICATION AGREEMENT OF CADISTA HOLDINGS INC.Pledge Modification Agreement • June 1st, 2011 • Cadista Holdings Inc. • New York
Pledge Modification Agreement made this 24 day of February, 2010, among CADISTA HOLDINGS INC. (hereinafter “Pledgor”), f/k/a Trigen Laboratories lnc., a Delaware corporation, with its principal place of business at 207 Kiley Drive, Salisbury, Maryland 21801, STATE BANK OF INDIA, NEW YORK BRANCH, a banking corporation duly licensed by the Superintendent of Banks of the State of New York and having its place of business at 460 Park Avenue, New York, N.Y. 10022, Facility Arranger, Administrative Agent, and Senior Lender (hereinafter, “Agent”), BANK OF BARODA, a banking corporation duly licensed by the Superintendent of Banks of the State of New York, and having its place of business at 1 Park Avenue, New York, NY 10016 (hereinafter, “BOB”), and CADISTA PHARMACEUTICALS INC., a Delaware corporation with its principal place of business at 207 Kiley Drive, Salisbury MD 21801 (hereinafter “Borrower”)
